Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biopharma's Narrowed Patent Protection May Find Relief In Trade Secret Law

Executive Summary

A new law intended to better secure trade secrets may also help biopharmaceutical companies safeguard their intellectual property in situations where protection isn't available under the patenting process or the scope of a firm's patent was narrowed because of recent Supreme Court rulings.


Related Content

World-Top Scientist Busted For Stealing GSK Secrets
US Capitol Capsule: Time To Get Aggressive Against Trade Secret Bandits
US Capitol Capsule: Obama takes aim at trade secret thieves, counterfeiters
Patent 'mischief' lurks after Myriad
Did SCOTUS slam the door on personalized medicine with Prometheus ruling?


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts